Involvement of PtdIns(4, 5)P2 in the Regulatory Mechanism of Small Intestinal P‐Glycoprotein Expression. Issue 2 (5th December 2013)

• Record Type: Journal Article
• Authors: Kobori, Takuro; Harada, Shinichi; Nakamoto, Kazuo; Tokuyama, Shogo
• Is Part Of: Journal of pharmaceutical sciences. Volume 103:Issue 2(2014:Feb.)
• Page Start: 743
• Page End: 751
• Publication Date: 2013-12-05
• Subjects: Pharmacy -- Periodicals; 615.1
• DOI: 10.1002/jps.23811
• Languages: English
• ISSNs: 0022-3549

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Previously, we reported that repeated oral administration of etoposide (ETP) activates the ezrin/radixin/moesin (ERM) scaffold proteins for P‐glycoprotein (P‐gp) via Ras homolog gene family member A (RhoA)/Rho‐associated coiled‐coil containing protein kinase (ROCK) signaling, leading to increased ileal P‐gp expression. Recent studies indicate that phosphatidyl inositol 4, 5‐bisphosphate [PtdIns(4, 5)P2] regulates the plasma‐membrane localization of certain proteins, and its synthase, the type I phosphatidyl inositol 4‐phosphate 5‐kinase (PI4P5K), is largely controlled by RhoA/ROCK. Here, we examined whether PtdIns(4, 5)P2 and PI4P5K are involved in the increased expression of ileal P‐gp following the ERM activation by ETP treatment. Male ddY mice (4‐week‐old) were treated with ETP (10 mg/kg/day, per os, p.o.) for 5 days. Protein‐expression levels were measured by either western blot or dot blot analysis and molecular interactions were assessed using immunoprecipitation assays. ETP treatment significantly increased PI4P5K, ERM, and P‐gp expression in the ileal membrane. This effect was suppressed following the coadministration of ETP with rosuvastatin (a RhoA inhibitor) or fasudil (a ROCK inhibitor). Notably, the PtdIns(4, 5)P2 expression in the ileal membrane, as well as both P‐gp and ERM levels coimmunoprecipitated with anti‐PtdIns(4, 5)P2 antibody, were increased by ETP treatment. PtdIns(4, 5)P2 and PI4P5K may contribute to the increase in ileal P‐gp expression observed following the ETP treatment, possibly through ERM activation via the RhoA/ROCK pathway. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:743–751, 2014</p> </abstract>